In late stage breast cancer tissues, transient expression of miR-181b is activated by STAT3, a transcription factor activated by IL-6 [51], which results eventually in upregulation of NF-kB and downregulation of let-7a [52, 53]. The gene discussed is IL6; the disease is breast cancer.